Ketamine (KET) Rapid Test – Saliva Screening Device

A Ketamine Saliva Rapid Test is used to screen oral fluid for possible ketamine exposure. Saliva testing is widely preferred in many drug screening programs because the specimen is easy to collect, does not require urine handling, and can support fast on-site testing. The Ketamine (KET) Rapid Test by LARKSOIS Pharma is suitable for professional screening workflows where same-day or recent-use screening is more relevant than long historical exposure testing.

• Saliva testing is useful because it is practical, non-invasive, and suitable for observed collection. This makes the KET Saliva Test useful in settings where sample integrity and quick testing are important.
• Oral fluid testing usually focuses on recent exposure. It may have a shorter detection window than hair or urine testing, but it is useful for fast and convenient preliminary screening.
• The Ketamine Saliva Rapid Test can support workplace drug abuse screening, clinical toxicology screening, rehabilitation monitoring, forensic testing, roadside screening where permitted, and international diagnostic distribution.

The Ketamine (KET) Saliva Rapid Test by LARKSOIS Pharma can be used across multiple professional settings where preliminary ketamine screening support is required.

Applications

• Workplace drug abuse screening
• Clinical and toxicology screening
• Rehabilitation and recovery monitoring
• Forensic and institutional testing
• Roadside or safety-sensitive screening where permitted
• On-site preliminary screening programs
• International diagnostic distribution
• Laboratory and professional screening workflows

The 20ng/ml cut-off means the Ketamine (KET) Saliva Rapid Test is designed to screen saliva specimens at this threshold. If the ketamine concentration in the saliva specimen meets or exceeds the cut-off level, the test may show a presumptive positive result. If the concentration is below the cut-off level, the test may show a negative result. The cut-off level helps standardize screening interpretation, but results can still be affected by sample quality, collection timing, oral fluid volume, storage conditions, test handling, and reading time.

• The Ketamine (KET) Rapid Test works through a rapid immunoassay principle. The saliva specimen interacts with specific reagents inside the test device.
• The device then produces a visible result according to the product insert. The test is designed for qualitative screening, meaning it indicates whether ketamine is detected above or below the product cut-off.
• The test does not measure the exact concentration of ketamine in the specimen. Confirmatory laboratory testing may be required for non-negative results depending on the testing purpose.

Instructions

• Saliva-based ketamine drug abuse screening
• 20ng/ml cut-off level
• Rapid test method for preliminary detection
• Non-invasive specimen collection
• Suitable for professional screening programs
• Supports recent-use screening requirements
• Useful for workplace, clinical, forensic, and rehabilitation settings
• Practical for on-site and institutional testing
• Suitable for international diagnostic supply
• Supplied by LARKSOIS Pharma for global markets

The Ketamine (KET) Saliva Rapid Test uses a rapid screening method for qualitative detection of ketamine exposure in saliva specimens. It is designed to provide a preliminary screening result at the stated 20ng/ml cut-off.

Benefits

• Saliva-based rapid screening format
• 20ng/ml ketamine cut-off
• Designed for KET drug screening
• Suitable for professional diagnostic use
• Supports recent-use screening programs
• Useful for clinical, workplace, rehabilitation, forensic, and institutional workflows
• Applicable for laboratories, hospitals, diagnostic centers, and distributors
• Supports international drug screening requirements

The Ketamine (KET) Rapid Test is designed for saliva specimens. Saliva testing is useful where non-invasive collection, observed sampling, and quick preliminary screening are important.

Guidance

• Use saliva specimen only
• Follow the product insert carefully
• Collect saliva using the approved collection method
• Avoid eating, drinking, or contaminating the sample before collection as per testing protocol
• Interpret results within the stated reading window
• Use confirmatory testing where required by clinical, legal, workplace, forensic, or institutional policy

Note

Saliva testing does not prove current impairment by itself. A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

• The KET saliva rapid test plays an important role in drug-of-abuse screening because ketamine misuse can create health, safety, workplace, and legal concerns.
• Saliva-based screening may be selected when organizations need fast, recent-use, and observed collection-based screening support.
• For global buyers, the Ketamine KET Saliva Rapid Test 20ng/ml is a useful product for diagnostic portfolios, drug testing panels, rehabilitation support, workplace safety programs, roadside screening where permitted, forensic screening, and institutional monitoring applications.

Steps

• Bring the test device and saliva collection materials to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect saliva according to the approved collection method
• Apply the saliva specimen according to the test instructions
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Ketamine (KET) Saliva Rapid Test.

Positive

A positive or non-negative result suggests that ketamine may be present in the saliva specimen at or above the stated cut-off. Positive results are preliminary and should be confirmed using a recognized laboratory method where required.

Negative

A negative result suggests that ketamine was not detected or was below the cut-off at the time of testing. A negative result does not always rule out exposure if sample quality, collection timing, or the detection window affects the result.

Invalid

If the valid control indicator does not appear, the test is invalid. The test should be repeated with a new device and properly collected saliva specimen according to the product insert.

Instructions

• Store in a cool and dry place
• Keep away from direct sunlight
• Do not freeze the test device
• Keep sealed until use
• Do not use damaged or opened pouches
• Do not use after the expiry date
• Follow the storage temperature mentioned on the label

Note

Proper storage helps protect the reliability and stability of the Ketamine Saliva Rapid Test 20ng/ml.

Instructions

• For professional in-vitro screening use only
• Use saliva specimen only as directed
• Do not reuse the test device
• Follow the product insert carefully
• Avoid eating, drinking, or contaminating the sample before collection as per testing protocol
• Wear gloves and follow standard hygiene practices
• Handle all specimens as potentially infectious material
• Confirm presumptive positive results with laboratory testing
• Follow local regulations for drug abuse testing and reporting

LARKSOIS Pharma provides professional diagnostic and pharmaceutical solutions for global markets. The Ketamine (KET) Rapid Test for saliva is designed for buyers who require a practical, reliable, and internationally suitable drug abuse screening product.

Advantages

• International-quality product approach
• Professional drug of abuse rapid test portfolio
• Suitable for bulk and institutional supply
• Practical saliva-based screening format
• Distributor-friendly product range
• Focus on quality, usability, and consistency
• Suitable for workplace, forensic, clinical, and rehabilitation markets